A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. [electronic resource]
Producer: 20180305Description: 128 p. digitalISSN:- 1745-6215
- Administration, Ophthalmic
- Angiogenesis Inhibitors -- administration & dosage
- Clinical Protocols
- Double-Blind Method
- Europe
- Glaucoma, Neovascular -- etiology
- Gonioscopy
- Humans
- Insulin Receptor Substrate Proteins -- genetics
- Intraocular Pressure -- drug effects
- Neovascularization, Pathologic
- Oligonucleotides -- administration & dosage
- Ophthalmic Solutions
- Prospective Studies
- Research Design
- Retinal Neovascularization -- etiology
- Retinal Vein Occlusion -- complications
- Signal Transduction -- drug effects
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- metabolism
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.